Active Pharmaceutical Ingredient

Rivoglitazone — CAS 442201-24-3

Also known as: CS-011; Rivoglitazone HCl

GMP Certified IP / BP / EP / USP Thiazolidinedione / PPARγ Agonist / Antidiabetic Aurangabad, India
Rivoglitazone API Supplier Manufacturer Aurangabad Maharashtra India — Mediocon Inc
Rivoglitazone IP / BP / EP / USP  |  GMP Certified  |  Mediocon Inc, Maharashtra, India
CAS No: 442201-24-3

Product Overview

Rivoglitazone is a high-purity Active Pharmaceutical Ingredient (API) classified under Thiazolidinedione / PPARγ Agonist / Antidiabetic. Mediocon Inc manufactures GMP-compliant Rivoglitazone at its state-of-the-art facility in Aurangabad, Maharashtra, India, supplying pharmaceutical companies worldwide with consistent quality and full regulatory documentation.

Therapeutic Applications
  • Type 2 diabetes mellitus management
  • PPARγ agonist therapy
  • Insulin sensitization
  • Metabolic syndrome research

Technical Specifications

ParameterSpecification
CAS Number442201-24-3
Molecular FormulaC₂₁H₂₁FN₂O₄S
Molecular Weight420.47 g/mol
GradeIP / BP / EP / USP
CategoryThiazolidinedione / PPARγ Agonist / Antidiabetic
AssayNLT 98.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Batch NoRIIVG/24032026
Mfg DateMAR 2026
Exp DateFEB 2031
Packing25 kg HDPE drums / as per requirement

Quality & Compliance

  • GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
  • Full pharmacopoeial compliance: IP / BP / EP / USP standards
  • Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
  • Stringent in-process quality control at every manufacturing stage
  • HPLC purity testing and spectroscopic identification (IR, NMR)
  • Cold-chain and controlled-environment storage facilities available
  • Exported to 40+ countries with full regulatory support
💬
Mediocon AI
Hello 👋 How can I help you today?